These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28624188)

  • 1. A Novel Single-Strand RNAi Therapeutic Agent Targeting the (Pro)renin Receptor Suppresses Ocular Inflammation.
    Kanda A; Ishizuka ET; Shibata A; Matsumoto T; Toyofuku H; Noda K; Namba K; Ishida S
    Mol Ther Nucleic Acids; 2017 Jun; 7():116-126. PubMed ID: 28624188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor.
    Liu Y; Kanda A; Wu D; Ishizuka ET; Kase S; Noda K; Ichihara A; Ishida S
    Mol Ther Nucleic Acids; 2019 Sep; 17():113-125. PubMed ID: 31254924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy.
    Kanda A; Ishida S
    J Diabetes Investig; 2019 Jan; 10(1):6-17. PubMed ID: 29575757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-associated prorenin system in the pathogenesis of retinal diseases.
    Satofuka S; Kanda A; Ishida S
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1449-60. PubMed ID: 22652885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane.
    Dong Y; Kanda A; Noda K; Saito W; Ishida S
    Sci Rep; 2017 Mar; 7():44266. PubMed ID: 28276504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.
    Kanda A; Ishida S
    Inflamm Regen; 2016; 36():22. PubMed ID: 29259695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of (pro)renin receptor in diabetic retinopathy].
    Satofuka S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1015-24. PubMed ID: 22171507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
    Ishida S
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
    Ishizuka ET; Kanda A; Shinmei Y; Ohguchi T; Tagawa Y; Hase K; Yamamoto T; Noda K; Chin S; Ishida S
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32707887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
    Kanda A
    Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):916-26. PubMed ID: 25543383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the receptor-associated prorenin system in the pathogenesis of human conjunctival lymphoma.
    Ishizuka ET; Kanda A; Kase S; Noda K; Ishida S
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):74-80. PubMed ID: 25503453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocytes as a target of prorenin in diabetes.
    Sakoda M; Itoh H; Ichihara A
    Curr Diabetes Rev; 2011 Jan; 7(1):17-21. PubMed ID: 21067509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases?
    Sun Y; Danser AHJ; Lu X
    Pharmacol Res; 2017 Nov; 125(Pt A):48-56. PubMed ID: 28532817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets of renin-angiotensin system in ocular disorders.
    Choudhary R; Kapoor MS; Singh A; Bodakhe SH
    J Curr Ophthalmol; 2017 Mar; 29(1):7-16. PubMed ID: 28367520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years of the (pro)renin receptor.
    Nguyen G
    J Am Soc Hypertens; 2008; 2(2):59-63. PubMed ID: 20409887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
    Feldt S; Batenburg WW; Mazak I; Maschke U; Wellner M; Kvakan H; Dechend R; Fiebeler A; Burckle C; Contrepas A; Jan Danser AH; Bader M; Nguyen G; Luft FC; Muller DN
    Hypertension; 2008 Mar; 51(3):682-8. PubMed ID: 18212269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles of (pro)renin receptor-bound prorenin in diabetes and hypertension: sallies into therapeutic approach.
    Ichihara A; Itoh H; Inagami T
    J Am Soc Hypertens; 2008; 2(1):15-9. PubMed ID: 20409880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin/prorenin receptor, (P)RR, in end-organ damage: current issues in 2007.
    Inagami T; Nakagawa T; Ichihara A; Suzuki F; Itoh H
    J Am Soc Hypertens; 2008; 2(4):205-9. PubMed ID: 20409904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of the (Pro)renin Receptor/Atp6ap2 with H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate Intercalated Cell H+-ATPase Activity.
    Daryadel A; Bourgeois S; Figueiredo MF; Gomes Moreira A; Kampik NB; Oberli L; Mohebbi N; Lu X; Meima ME; Danser AH; Wagner CA
    PLoS One; 2016; 11(1):e0147831. PubMed ID: 26824839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.
    Jansen PM; Hofland J; van den Meiracker AH; de Jong FH; Danser AH
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):360-6. PubMed ID: 22396488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.